Overexpression of PRL in patients with diabetic retinopathy results in accumulation of vasoinhibins in the retina, inhibition of vascular endothelial growth factor (VEGF), inactivation of nitric oxide synthase (NOS), and prevention of retinal vasopermeability [23,25,26,27,28,29]. This evidence concerns the gene PRL and diabetic retinopathy.